-Shokei Kim-Mitsuyama Researcher Activity Profile

Research Author Detailed Information 

Shokei Kim-Mitsuyama Publication Rate By Year

Shokei Kim-Mitsuyama has published 8 paper(s) in 2007, 2 paper(s) in 2008, for a total of 10 research publications in total.

Shokei S Kim-Mitsuyama Author Information

LAST NAME: kim-mitsuyama

FIRST NAME: shokei

INITIALS: S

AFFILIATION:

Papers

Shokei Kim-Mitsuyama's Publication Record

1. Protein S-guanylation by the biological signal 8-nitroguanosine 3',5'-cyclic monophosphate. Year Published: 2007
Department of Microbiology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan.
2. Inhibition of p38MAP kinase suppresses fibrogenic reaction in conjunctiva in mice. Year Published: 2007
Department of Ophthalmology, Wakayama Medical University, Wakayama, Japan. yamanaka@wakayama-med.ac.jp
3. Pioglitazone exerts protective effects against stroke in stroke-prone spontaneously hypertensive rats, independently of blood pressure. Year Published: 2007
Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjyo, Kumamoto 860-8556, Japan.
4. Oxidation of Prx2 and phosphorylation of GRP58 by angiotensin II in human coronary smooth muscle cells identified by 2D-DIGE analysis. Year Published: 2007
Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Honjo 1-1-1, Kumamoto 860-8556, Japan.
5. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure. Year Published: 2007
Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjyo, Kumamoto 860-8556, Japan.
6. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure. Year Published: 2007
Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjyo, Kumamoto 860-8556, Japan.
7. Oxidation of Prx2 and phosphorylation of GRP58 by angiotensin II in human coronary smooth muscle cells identified by 2D-DIGE analysis. Year Published: 2007
Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Honjo 1-1-1, Kumamoto 860-8556, Japan.
8. Protein S-guanylation by the biological signal 8-nitroguanosine 3',5'-cyclic monophosphate. Year Published: 2007
Department of Microbiology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan.
9. Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan. Year Published: 2008
Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjyo, Kumamoto 860-8556, Japan. kimmitsu@gpo.kumamoto-u.ac.jp.
10. Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan. Year Published: 2008
Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjyo, Kumamoto 860-8556, Japan.